IDEXX Laboratories Inc
F:IX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IDEXX Laboratories Inc
F:IX1
|
US |
|
Dynamix Corp
NASDAQ:ETHM
|
US |
|
AFC Ajax NV
F:AJXA
|
NL |
|
Tele2 AB
F:NCY
|
SE |
|
C
|
China Water Affairs Group Ltd
XMUN:CUBB
|
HK |
|
P
|
Pulmatrix Inc
F:2PU1
|
US |
|
UFP Technologies Inc
F:UFP
|
US |
|
I
|
Insulet Corp
F:GOV
|
US |
|
C
|
Callaway Golf Co
XBER:CLY
|
US |
|
F
|
Funko Inc
F:FU2
|
US |
|
M
|
Muangthai Capital PCL
SET:MTC
|
TH |
|
C
|
Consolidated Water Co Ltd
F:CW2
|
KY |
|
Teradyne Inc
NASDAQ:TER
|
US |
|
T
|
Teva Pharmaceutical Industries Ltd
BMV:TEVAN
|
IL |
|
S
|
Stryker Corp
F:SYK
|
US |
|
C
|
Celanese Corp
XMUN:DG3
|
US |
Wall St Price Targets
IX1 Price Targets Summary
IDEXX Laboratories Inc
According to Wall Street analysts, the average 1-year price target for IX1 is 639.12 EUR with a low forecast of 406.04 EUR and a high forecast of 731.06 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IX1's stock price target?
Price Target
639.12
EUR
According to Wall Street analysts, the average 1-year price target for IX1 is 639.12 EUR with a low forecast of 406.04 EUR and a high forecast of 731.06 EUR.
What is the Revenue forecast for IDEXX Laboratories Inc?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for IDEXX Laboratories Inc?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 8 years is 13%.
What is the Net Income forecast for IDEXX Laboratories Inc?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 8 years is 14%.
